Form 4: National Healthcare Corp Director Richard F. LaRoche Jr. Reports Option Grant
SEC Form 4
Director Richard F. LaRoche Jr. reports the grant of stock options in National Healthcare Corp.
Summary
- Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), filed a Form 4.
- The filing reports the grant of 7,500 stock options on May 8, 2025, at an exercise price of $94.66.
- These options were granted pursuant to the 2020 Omnibus Equity Incentive Plan and become exercisable on May 8, 2026, expiring on May 7, 2030.
- LaRoche also holds various other common stock positions directly, indirectly, and through family partnerships and a ROTH IRA.
- The filing details existing option holdings from previous grants in 2021, 2022, 2023 and 2024.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of an option grant, which is generally neutral. It indicates alignment of the director's interests with shareholders, but doesn't provide strong positive or negative signals.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
Industry Context
Option grants are a common practice in the healthcare industry to incentivize executives and align their interests with shareholders.
Comparison to Industry Standards
- Option grants are a standard component of executive compensation packages across the healthcare industry.
- Companies like Brookdale Senior Living and Life Care Centers of America also utilize stock options as part of their compensation strategy.
- The size and vesting schedule of the grant are generally in line with industry norms for director-level compensation.
Stakeholder Impact
- The option grant could potentially increase shareholder value if the director's performance leads to stock appreciation.
- The grant incentivizes the director to make decisions that benefit the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 05/06/2022 | Date exercisable for 2021 option grant |
| 05/05/2023 | Date exercisable for 2022 option grant |
| 05/04/2024 | Date exercisable for 2023 option grant |
| 05/08/2025 | Date of option grant and date exercisable for 2024 option grant |
| 05/08/2026 | Date exercisable for 2025 option grant |
| 05/05/2026 | Expiration date for 2021 option grant |
| 05/04/2027 | Expiration date for 2022 option grant |
| 05/03/2028 | Expiration date for 2023 option grant |
| 05/08/2029 | Expiration date for 2024 option grant |
| 05/07/2030 | Expiration date for 2025 option grant |
Keywords
stock options, Form 4, director, National Healthcare Corp, NHC, Richard F. LaRoche Jr., equity incentive plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.